Author Guidelines

Online Submission

Article Publishing Charges:

Open Access Publication: All manuscripts submitted to the “Journal of Pharmaceutical Science Letters” BioPharm Publisher are assumed to be submitted under the Open Access publishing model. In this publishing model, papers are rigorous peer-reviewed in the normal way under editorial control. When a paper is accepted for publication the author is issued with an invoice for payment of an article publishing charge (see payment details below). There is no submission charge as such, only the article publishing charge after the paper is accepted for publication. Payment of this charge allows BioPharm Publisher to recover its editorial and production costs.

Published papers appear electronically and are freely available from our website. Authors may also use their published .pdf's for any non-commercial use on their personal or non-commercial institution's website.

Upon acceptance for publication a publishing charge will be payable.

(Indian Authors: Rs. 3000 & for Foreign authors: USD $. 150).

Once the manuscript accepted & informed to the corresponding author with unlocked payment gateway link code will be opened for payment of publication fees.  Owing to fluctuations in foreign exchange rates fees may occasionally be subject to change without notice.

“As an introductory offer for these journals offers complete waiver for APC from January 2023 to December 2023 and you can publish free of charge”.

As this title is newly launched, it does not have a CiteScore or Journal Impact Factor yet, however we will apply for inclusion in all the relevant indexing databases as soon as possible.

Commercial use: No articles from the BioPharm Publisher website may be reproduced, in any media or format, or linked to for any commercial purpose (eg. product support, etc) without the prior written consent of BioPharm Publisher and payment to BioPharm Publisher of an appropriate fee.

Color illustrations: Open Access papers appear electronically. As no printed issues of any BioPharm Publisher Journals are produced there are NO additional charges for color illustrations.  

Discretionary waivers
We will consider all requests for discretionary APC waivers by researchers who aren’t eligible for the above. Please state your request for a discretionary waiver prior to submitting your manuscript by email to the APC Team (info@biopharmpublisher.com).
Please include supporting evidence for why a waiver would be necessary in your circumstances.  Your request should include details of:

• The affiliation and country of residence of all authors.
• Details of where the research was conducted.
• Confirmation of all research grant funding received. 

If you have already accepted a discounted price offered to you at the time of submission please be aware that this is the maximum discount and we are unable to help you further.

Discounts may not be combined and where multiple discounts are available the one most favorable to the author will apply.

 Author Instructions:

• An online submission and tracking service via Internet facilitates a speedy and cost-effective submission of manuscripts. Manuscripts and the full thematic issues must be submitted online.
• Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research.
• No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient.
• Work which is predictable in outcome, will not be published unless it provides new insight into fundamental principles.
• For all online submissions, provide soft copies of all the materials (main text in MS Word), figures/illustrations in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw (CDX)/ISISDraw (TGF) as separate files, while a PDF version of the entire manuscript must also be included, embedded with all the figures/illustrations/tables/chemical structures etc .
• It is advisable that the document files related to a manuscript submission should always have the name of the corresponding author as part of the file name, i.e., “Yan MS text.doc” ,“Yan MS Figure 1”, etc.
• It is imperative that before submission, authors should carefully proofread the files for special characters, mathematical symbols, Greek letters, equations, tables, references and images, to ensure that they appear in proper format.
• References, figures, tables, chemical structures etc. should be referred to in the text at the appropriate place where they have been first discussed. Figure legends/captions should also be provided.
• A successful electronic submission of a manuscript will be followed by a system-generated acknowledgement to the principal/corresponding author.
• Any queries therein should be addressed to info@biopharmpublisher.com

Article types

- Research articles: Reports of original unpublished research work; not normally more than 8500 words (10 journal pages). Papers on nano- and microscale theories, technologies, engineering and applications should include some representative results. Claims for originality or novelty of researches should be clearly stated in the abstracts.

- Rapid communications: Brief, urgent announcements of significant advances or preliminary accounts of new work, not more than 3500 words (4 journal pages). The most important criteria for acceptance of a Rapid communication are novelty and significance. For these articles authors must state briefly, in a covering letter, exactly why their works merits rapid publication.

- Review articles: These are intended to summarize accepted practice and report on recent progresses in selected areas. Such articles are generally commissioned from experts in various fields by the Editorial Board, but others wishing to write a Review article may submit an outline for preliminary consideration.

Format & layout of your article

Keep your writing clear and concise, avoiding repetition or embellishment. All submissions must be in English. Use times new roman font 12 size, 1.5 line spacing and all the pages should be numbered at the right bottom. We permit standard English and American spelling in our journals, but please use one or the other consistently within the article itself. You are welcome to use common or standard abbreviations; if your abbreviations are non-standard, please include a definition the first time you use them.

All articles accepted for publication in our journals are edited and typeset to our house style by professional editors: the manuscript will be formatted for you.

Sections in Manuscripts

Manuscripts submitted for research and review articles in the journal should be divided into the following sections:

• Title page
• Abstract
• Keywords
• Text Organization
• Conclusion
• List of Abbreviations (if any)
• Consent for Publication
• Funding
• Conflict of Interest
• Acknowledgements
• References
• Appendices
• Figures/Illustrations (if any)
• Chemical Structures (if any)
• Tables (if any)
• Supportive/Supplementary Material (if any)

Title

The title should be short and straightforward to appeal to a general reader, but detailed enough to properly reflect the contents of the article.

Keep it relatively short

Use easily recognizable words and phrases that can be read quickly

Use keywords and familiar, searchable terms – these can increase the chances of your article appearing in search results. Around

70% of our readers come directly via search engines

Use general terms for compounds and procedures rather than specific nomenclature or very specialised terms

Avoid using non-standard abbreviations and symbols;

Authorship

Full names and affiliations for all the authors should be included. Everyone who made a significant contribution to the conception, design or implementation of the work should be listed as co-authors. The corresponding author has the responsibility to include all (and only) co-authors. The corresponding author also signs a copyright license on behalf of all the authors. Click here to download Copyright Form.

If there are more than 10 co-authors on the manuscript, the corresponding author should provide a statement to specify the contribution of each co-author. It is possible to have two corresponding authors. Please identify co-corresponding authors on your manuscript's first page and also mention this in your comments to the editor and/or cover letter.

Abstract

The abstract is the first part of your manuscript that editors, reviewers and potential readers will see. It will help readers to decide whether your article is of interest to them. Therefore, it’s important that it clearly and concisely summarizes the main findings of your research and why they are important.

The abstract is a single paragraph which should:

Be around 50 to 250 words; concise and easy to read with recognizable words and phrases

Use familiar, searchable terms and keywords

Set out the main objectives and results of the work; it should give the reader a clear idea of what has been achieved

Emphasize (but not overstate) the potential impact of the research and why it is important (compared to other research in its field)

Avoid including detailed information on how the research was carried out; this should be described in the main part of the manuscript

Section Headings

Section headings should be numbered sequentially, left aligned and have the first letter capitalized, starting with the introduction. Sub-section headings however, should be in lower-case and italicized with their initials capitalized. They should be numbered as 1.1, 1.2, etc. A page break may be inserted to keep a heading along with its text.

Introduction

An introduction should 'set the scene' of the work. It should clearly explain both the nature of the problem under investigation and its background. It should start off general and then focus in to the specific research question you are investigating. Ensure you include all relevant references.

Experimental

You should provide descriptions of the experiments in enough detail so that a skilled researcher is able to repeat them. Standard techniques and methods used throughout the work should just be stated at the beginning of the section; descriptions of these are not needed. Any unusual hazards about the chemicals, procedures or equipment should be clearly identified.

Results & discussion

This is arguably the most important section of your article.

Your results should be organized into an orderly and logical sequence. Only the most relevant results should be described in the text; to highlight the most important points. Figures, tables, and equations should be used for purposes of clarity and brevity. Data should not be reproduced in more than one form, for example in both figures and tables, without good reason.

The purpose of the discussion is to explain the meaning of your results and why they are important. You should state the impact of your results compared with recent work and relate it back to the problem or question you posed in your introduction. Ensure claims are backed up by evidence and explain any complex arguments.

Conclusions

This is for interpretation of the key results and to highlight the novelty and significance of the work. The conclusions should not summaries information already present in the article or abstract. Plans for relevant future work can also be included.

Conflicts of interest

In accordance with our policy on Conflicts of interest please ensure that a conflicts of interest statement is included in your manuscript here.  Please note that this statement is required for all submitted manuscripts.  If no conflicts exist, please state that ‘There are no conflicts to declare’.

Acknowledgements

Contributors (that are not included as co-authors) may be acknowledged; they should be as brief as possible. All sources of funding should be declared.

Referencing in The Text

The reference source of statements in the text – for example, reactive small molecule species (Yen et al, 2020; Yen and Young 2020; Yen M 2020).

Listing your references

The references themselves are listed in Alphabetical order at the end of the main article. The names and initials of all authors should be given in the reference.

Journal articles

Journal articles should be cited in the form: Name A, Name B, Name C. Article title. Journal Name, year, volume, page & doi (if doi available).

Yang C, Wu T, Qi Y, Zhang Z. Recent Advances in the Application of Vitamin E TPGS for Drug Delivery. Theranostics. 2018; 8(2): 464–485. doi: 10.7150/thno.22711.

Books

2000. Name, B. Name and C. Name, Book Title, Publisher, Publisher Location, year. For example, S T Beckett, Science of Chocolate, Royal Society of Chemistry, Cambridge, 2000. If you are referencing published conference proceedings, these should be cited like a book.

Book chapters

1. Name, in Book Title, ed. Editor Name(s), Publisher, Publisher Location, edition, year, chapter, pages. The ‘ed.’ in the example above stands for ‘edited by’, that is, the editor(s) of the book; if the book has no editors this can be left out.

Theses

1. Name, PhD thesis, University Name, year.

Reference to unpublished material

If you reference unpublished material in your article you must provide the editor with copies of the manuscripts with your submission. You should not reference unpublished work without the permission of those who completed the work.

For material accepted for publication, but not yet published: A. Name, Journal Title, in press. For material submitted for publication, but not yet accepted: A. Name, Journal Title, submitted. For material that has yet to be submitted for publication: A. Name, unpublished work.

Online resources (including databases, websites & wikis)

Name of resource, URL, (accessed date). Please note the most important information to include is the URL and the date accessed. For example, The Merck Index Online, http://www.rsc.org/Merck-Index/monograph/mono1500000841, (accessed October 2013).

Patents

You should provide the name of the patentee(s), patent issuer, patent number and year. For example: J. C. Chung, US Pat., 20100105549A1, 2010; Nippon Telegraph & Telephone, Jpn. Pat., 2013034915A, 2013.

Figures / Tables

Figures/Illustrations

• All authors must strictly follow the guidelines below for preparing illustrations for publication in BioPharm Publisher journals.
• If the figures are found to be sub-standard, then the manuscripts will be rejected.
• The authors are expected to submit good quality figure(s) in PDF, PPT, MS Word, TIFF or JPEG versions, which, if required, should be improved yourself or by professional graphic designers of your organization/ country.

Scaling/Resolution

• Line Art image type is normally an image based on lines and text. It does not contain tonal or shaded areas. The preferred file format should be TIFF or EPS, with the color mode being Monochrome 1-bit or RGB, in a resolution of 900-1200 dpi.
• Halftone image type is a continuous tone photograph containing no text. It should have the preferred file format TIFF, with color mode being RGB or Grayscale, in a resolution of 300 dpi.
• Combination image type is an image containing halftone, text or line art elements. It should have the preferred file format TIFF, with color mode being RGB or Grayscale, in a resolution of 500-900 dpi.
• All images submission requirements: 8.5 inches Width, 11 inches Hight at the maximum and 300dpi minimum pixel.

Tables:

• Data Tables should be submitted in Microsoft Word table format.
• Each table should include a title/caption being explanatory in itself with respect to the details discussed in the table. Detailed legends may then follow.
• Table number in bold font i.e. Table 1, should follow a title. The title should be in small case with the first letter in caps. A full stop should be placed at the end of the title.

Tables should be embedded in the text exactly according to their appropriate placement in the submitted manuscript.

 Copyright / Archiving Policy

Copyright

• Authors who publish in BioPharm Publisher & online journals will transfer copyright to their work to BioPharm Publisher.
• Submission of a manuscript to the respective journals implies that all authors have read and agreed to the content of the Copyright Letter or the Terms and Conditions.
• It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere.
• Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered.
• By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
• Once submitted to the journal, the author will not withdraw their manuscript at any stage prior to publication.

Copyright Letter

• It is mandatory that a signed copyright letter should also be submitted along with the manuscript by the author to whom correspondence is to be addressed, delineating the scope of the submitted article declaring the potential competing interests, acknowledging contributions from authors and funding agencies, and certifying that the paper is prepared according to the 'Instructions for Authors’.
• All inconsistencies in the text and in the reference section and any typographical errors must be carefully checked and corrected before the submission of the manuscript.
• The article should not contain any such material or information that may be unlawful, defamatory, fabricated, plagiarized, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the copyright agreement.
• The authors acknowledge that the publishers have the legal right to take appropriate action against the authors for any such violation of the terms and conditions as laid down in the copyright agreement.

Privacy Statement

• The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Reviewer Guidelines:

• Peer review, also known as refereeing, is a collaborative process that allows independent experts in the same field of research to evaluate and comment on manuscript submissions.
• The outcome of a peer review gives authors feedback to improve their work and, critically, allows the editor to assess the paper’s suitability for publication.

Why should you become a peer reviewer?

• Peer reviewing is a form of collaboration between experts. Their critical feedback often improves research and helps propel it forward.

Peer Review Process:

• The journal receives a paper.
• The journal editor checks the paper against the journal’s aims and scope.
• The editor then selects reviewers (usually 2-3 peers) and sends the paper.
• The reviewers read the paper and provide comments, suggestions and a recommendation (reject, revise or accept).
• The editor checks the reviews and sends them to the author(s), with any extra guidance.
• If there are revisions, the author(s) decides whether to make these and re-submit.
• Authors make amendments and re-submit the paper.
• If the journal accepts the paper, it moves into production and is published.

Write your review report

The two main factors you should provide advice on are:

• The originality, presentation, and relevance of the manuscript’s subject matter to the readership of the journal

the accuracy of the methodology.

Here is a checklist to consider when reading the manuscript:

• First read-through
• Detailed review – Research articles
• Final checks – before you submit your report
• Peer review of non-research articles

Provide detailed comments

• These should be suitable for sending to the author.
• Use these comments to make constructive suggestions, seek clarification on any unclear points, and ask for further elaboration.
• Make suggestions on how the author can improve clarity, succinctness, and the quality of presentation.
• Confirm whether you feel the subject of the paper is sufficiently interesting to justify its length.
• If you recommend shortening, show specific areas where you think it’s required.
• It’s not the reviewer’s job to edit the paper for English, but it is helpful if you correct the English where the technical meaning is unclear.
• A referee may disagree with the author’s opinions, but should allow them to stand, provided their evidence supports it.
• Remember that authors will welcome positive feedback as well as constructive criticism.
• Being critical whilst remaining sensitive to the author isn’t always easy.
• Comments should be carefully worded so the author understands what actions they need to take to improve their paper.
• Avoid generalized or vague statements as well as any negative comments which aren’t relevant or constructive.

Make a recommendation:

Once you’ve read the paper and have assessed its quality, you need to make a recommendation to the editor about publication.

The specific decision types used by a journal will vary, but the key decisions are:

Accept - The paper is suitable for publication in its current form.

Minor revision - The paper will be ready for publication after light revisions. Please list the revisions you would recommend the author makes.

Major revision - The paper needs substantial changes such as expanded data analysis, widening of the literature review, or rewriting sections of the text.

Reject. The paper isn’t suitable for publication with this journal, or the revisions are too fundamental for the submission to continue being considered in its current form.

Revisions

When authors make revisions to their article, they’re asked to submit a list of changes and any comments for the reviewers. The revised version is usually returned to the original reviewer if possible. The reviewer is then asked to affirm whether the revisions are satisfactory.

Awards:

Journal of Pharmaceutical Technology Letters Best Publications of the Year Award

Journal of Pharmaceutical Technology Letters Highest Citation of the Year Award

Online Submission (Login/Signup)

Submit a Manuscript:

If you haven't already registered with us, you will be asked to provide some basic information about yourself and we will then email you a link. This will allow you to complete your registration and continue your submission.

If you have already registered with us you can choose to log in below or be sent a link to continue your submission.

Login credentials

Author login

Reviewer login

Editor/Publisher login

Register now

Forget password

Help

Author Submission Page

Main Menu

New Submissions

1. Submit New Manuscript
2. Select Article Type (Research/Review/Commentary) - proceed
3. Author Details

First Author- Name; Affiliation; email; orcid id

second

4. Potential Suggested Peer Reviewers (3)
5. Opposed Reviewers (Optional)
6. Upload files (Cover Letter, Manuscript, Graphical Abstract, Images, Tables, Supplementary data, signed copyright letter)
7. Summary
8. Accept and Submit (Terms & conditions)

Finally the authors should access their status of manuscript at any time after submission in their login page.

Manuscript number assigned & should be informed to the author & editor in chief using automated email.

Status: (viewed by author)

With Editor

Under Review

Review Completed

Decision pending

Final Decision

Accept/ Reject/

Minor revision/ Major revision/ Substantial revision

(Author should have rights to submit their revised version of manuscript with same login)

Pre-submissions

• Authors are welcome to send an abstract of their manuscript to obtain a view from the Editor about the suitability of their paper.
• Our Editors will do a quick review (not peer review) of your abstract and advise if they believe it is appropriate for submission to their journal. It will not be a full review of your manuscript.

pre-submission form here.

• Authors who wish to submit an article to any of BioPharm Publisher Journals are requested to please complete the following online form with the proposed abstract of the article. 
• The abstract of the article will then be immediately forwarded to the Editor-in-Chief/Co-Editors/Executive Editor(s) of the relevant journal who will then inform the author with a decision about submitting the completed article.

Note: * Required fields

Abstract for the proposed Article:

(Please copy and paste the Abstract in the space provided below. You may also type it directly. The abstract should not exceed 250 words and it should condense the essential features of the review article, with the focus on the major advances in the field.)

* Title of the proposed Article:

 *Contributing Authors:

*Author Affiliations:

*Abstract:
*Keywords:

*Tentative date for submission of complete manuscript:

Contact Information:

*Title: Mr

*First Name:

*Last Name:

*User Category:

*Address:

*City/Town:

*Country:

*State/Province:

*Zip/Postal code:

*E-mail:

*Phone:

*Fax:

*Im not robot

*Submit